Cargando…

Haplotypes with Copy Number and Single Nucleotide Polymorphisms in CYP2A6 Locus Are Associated with Smoking Quantity in a Japanese Population

Smoking is a major public health problem, but the genetic factors associated with smoking behaviors are not fully elucidated. Here, we have conducted an integrated genome-wide association study to identify common copy number polymorphisms (CNPs) and single nucleotide polymorphisms (SNPs) associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumasaka, Natsuhiko, Aoki, Masayuki, Okada, Yukinori, Takahashi, Atsushi, Ozaki, Kouichi, Mushiroda, Taisei, Hirota, Tomomitsu, Tamari, Mayumi, Tanaka, Toshihiro, Nakamura, Yusuke, Kamatani, Naoyuki, Kubo, Michiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458030/
https://www.ncbi.nlm.nih.gov/pubmed/23049750
http://dx.doi.org/10.1371/journal.pone.0044507
Descripción
Sumario:Smoking is a major public health problem, but the genetic factors associated with smoking behaviors are not fully elucidated. Here, we have conducted an integrated genome-wide association study to identify common copy number polymorphisms (CNPs) and single nucleotide polymorphisms (SNPs) associated with the number of cigarettes smoked per day (CPD) in Japanese smokers ([Image: see text] = 17,158). Our analysis identified a common CNP with a strong effect on CPD (rs8102683; [Image: see text]) in the 19q13 region, encompassing the CYP2A6 locus. After adjustment for the associated CNP, we found an additional associated SNP (rs11878604; [Image: see text]) located 30 kb downstream of the CYP2A6 gene. Imputation of the CYP2A6 locus revealed that haplotypes underlying the CNP and the SNP corresponded to classical, functional alleles of CYP2A6 gene that regulate nicotine metabolism and explained 2% of the phenotypic variance of CPD (ANOVA [Image: see text]-test [Image: see text]). These haplotypes were also associated with smoking-related diseases, including lung cancer, chronic obstructive pulmonary disease and arteriosclerosis obliterans.